role in initiating the coagulation pathways that lead to thrombotic complication associated with plaque rupture. In animal models of balloon injury to arteries, exposure of TF in deeper layers of the vessel wall has been implicated in initiation and prolonged triggering of a procoagulant response in the vasculature (3) . TF makes diverse contributions to the pathophysiology of thromboembolic disease, so specific inhibition of the IF pathway may potentially be exploited as a novel anticoagulant strategy to prevent and intervene in intravascular thrombotic events. The biochemical characterization of function of the TFFVIIa complex has progressed rapidly in recent years and we review here the current understanding of the molecular basis for TF function within the context of the recently solved 3-dimensional structure of TF. The structural biology of TF may provide a paradigm for the structural basis of function of other receptor and cofactor molecules that are used by vascular cells to initiate downstream protease cascades involved in host defense and repair, regulation of migration, and cell-cell communication. to FVIIa binding. The N-linked glycosylation sites in IF are at residue Asn124, which is largely buried on strand B in the C-module, and at residues Asn and Asn137, which are well exposed to solvent and point surface. This core region is depicted in Fig. 2 . Phe19 packs in a pocket formed by several of the residues that form the hydrophobic core of the module interface (8) . Mutation of this residue affects correct processing and expression from the cell (9), potentially due to incorrect folding, suggesting that the interface structure is critical for folding of the molecule. Other specific mutations, particularly in the linker region from Iyr'#{176}3-Thr'#{176}6, affect function without apparent major structural alterations, indicating that the interface is also important for function of the molecule (9) . The membrane linker region (Met#{176}-Glu219) has not been implicated in function and this region is disordered in both X-ray structures (7, 8) .
THE MACROMOLECULAR LIGANDS FOR TF
The macromolecular ligands for TF are the serine protease FYlla and its zymogen precursor FY11. The zymogen is composed of an amino-terminal, y-carboxyglutamic acid-rich (Gla) domain, two epidermal growth factor-like (EGF) modules, a short region in which the proteolytic activation cleavage occurs, followed by a typical serine protease domain. FYIIa is a two-chain enzyme with the light chain (Gla-and EGF-modules) covalently linked to the heavy chain protease domain via a disulfide bridge. Both the zymogen and the protease bind the extracellular domain in a 1:1 stoichiometry (10) and the Kj of binding measured with soluble IF, which is truncated in the membrane linker region, is approximately 2-5 nM. This value is consistently reported using different methodology.
The methodology includes functional titration (11) (12) (13) or direct biophysical evaluation using surface plasmon resonance (14) . Soluble TF has a 20-fold reduced affinity for FVIIa as compared to full-length IF when analyzed with similar methodology under identical conditions (15 Most of these residue side chains were found to be well exposed to solvent in the crystal structure of TF, concordant with macromolecular ligand interaction. Figure  3 shows the topographical organization of the residues that make energetic contributions to the interaction with FYIIa. The FYIIa ligand binding site is located over an extensive region at the boundary between the two modules.
In the C-module, residues Arg'35 and Phe0 located on the protruding B-C loop provide an interdependent contact with ligand (11). Leu133 is located at the base of the fingerlike structure and packed in the cleft between the two modules.
This provides continuity to a major cluster of important binding residues consisting of Lys20, Thr60, Asp, and 11e22. Thr60 is only partially solvent exposed and may play a local structural role rather than making a significant contact with ligand. The binding site extends onto the concave side of the intermodule angle involving G1u24 (9) and G1n1 10, and potentially the more distant residue Val207 (13 Phe76 and Tyr78, which form part of the hydrophobic cluster in the N-module (32).
COMPARISON WITH RELATED RECEPTORS
The structure of neuroglian, a cell adhesion molecule containing tandem fibronectin type III modules, has recently been solved (33). The neuroglian molecule shows some similarity to TF, i.e., it has a-helical segments within the n-strand framework, including one in the B-C loop of the second module. Neuroglian has an extensive module inter- Binding residues with highest energetic contributions (G>4 kcal/mol) are shown in purple (Irp'#{176}4, Trp'); other significant binding contacts (&G>1 kcal/mol) are shown in mauve (Arg", Glu'', He'#{176}3, lle'#{176}5, Pro'#{176}6,
Asp,
Glu'27, AspiM, I1e'), according to the recent study by Clackson and Wells (54). macromolecular substrate.
The enhancement in catalytic function of the catalytic site is readily monitored with small peptidyl pseudosubstrates that are hydrolyzed with 20-to 100-fold increased catalytic rates (kt) in the presence of cofactor as compared to free enzyme F'VIIa (37). The activation of serine protease domains typically results in the formation of a critical salt bridge between the newly exposed amino terminus and the aspartate side chain adjacent to the catalytic serine. The protease domain amino-terminal Ile' in FYIIa can be carbamylated at the a-amino group (21), reflecting the labile nature of the Ile'-Asp'3 salt bridge in FYIIa. This modification reaction is inhibited by IF, indicating that the lability of the salt bridge may be the cause of the low catalytic activity of free FYIIa (38, 39) .
These data support a model where FYIIa is maintained in an active conformation by cofactor interaction. Several key contacts in the central FYIIa binding region involving the cofactor residues Lys20, 11e22, Arg'35, Phe'0, and Asp (Fig. 3) are the most significant contributors to the activation of factor X (48, 50). The side chains of these residues point in opposite directions and are well exposed to solvent at the lower end of the C-module (Fig. 5) 
